Erdheim-Chester Disease with Right Atrial Tumor and “Temporal Arteritis”
Affiliation(s)
Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester Minnesota, USA. Department of Pathology, Mayo Clinic College of Medicine, Rochester, USA. Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, USA.
Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester Minnesota, USA. Department of Pathology, Mayo Clinic College of Medicine, Rochester, USA. Division of Rheumatology, Mayo Clinic College of Medicine, Rochester, USA.
ABSTRACT
Erdheim-Chester disease is an unusual syndrome characterized by non-Langerhans cell histiocytosis which can mimic rheumatologic diseases. We report a case of Erdheim-Chester masquerading as giant cell arteritis, which was success-fully managed with anakinra as anti IL-1 therapy.
Erdheim-Chester disease is an unusual syndrome characterized by non-Langerhans cell histiocytosis which can mimic rheumatologic diseases. We report a case of Erdheim-Chester masquerading as giant cell arteritis, which was success-fully managed with anakinra as anti IL-1 therapy.
Cite this paper
J. Skalski, W. Edwards and E. Matteson, "Erdheim-Chester Disease with Right Atrial Tumor and “Temporal Arteritis”," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 2 No. 3, 2012, pp. 37-38. doi: 10.4236/ojra.2012.23008.
J. Skalski, W. Edwards and E. Matteson, "Erdheim-Chester Disease with Right Atrial Tumor and “Temporal Arteritis”," Open Journal of Rheumatology and Autoimmune Diseases, Vol. 2 No. 3, 2012, pp. 37-38. doi: 10.4236/ojra.2012.23008.
References
[1] J. Haroche, L. Arnaud and Z. Amoura, “Erdheim-Chester Disease,” Current Opinion in Rheumatology, Vol. 14, No. 1, 2012, pp. 53-59. doi:10.1097/BOR.0b013e32834d861d [2] A. Aouba, S. Georgin-Lavialle, C. Pagnoux, N. M. Silva, A. Renand, et al., “Rationale and Efficacy of Interleukin-1 Targeting in Erdheim-Chester Disease,” Blood, Vol. 116, No. 20, 2012, pp. 4070-4076. doi:10.1182/blood-2010-04-279240 [3] W. Chester, “über Lipoidgranulomatose,” Virchows Archive, Vol. 279, No. 2, 1930, pp. 561-602. doi:10.1007/BF01942684 [4] J. Haroche, P. Cluzel, D. Toledano, G. Montalescot, D. Touitou, et al., “Cardiac Involvement in Erdheim-Chester Disease: Magnetic Resonance and Computed Tomographic Scan Imaging in a Monocentric Series of 37 Patients,” Circulation, Vol. 119, No. 25, 2009, pp. e597-e598. doi:10.1161/CIRCULATIONAHA.108.825075 [5] E. C. Derrett-Smith and B. Dasgupta, “Erdheim-Chester Disease: Yet another Mimic of Polymyalgia Rheumatica and Giant Cell Arteritis?” Rheumatology, Vol. 44, No. 3, 2005, pp. iii14-iii15.
[1] J. Haroche, L. Arnaud and Z. Amoura, “Erdheim-Chester Disease,” Current Opinion in Rheumatology, Vol. 14, No. 1, 2012, pp. 53-59. doi:10.1097/BOR.0b013e32834d861d [2] A. Aouba, S. Georgin-Lavialle, C. Pagnoux, N. M. Silva, A. Renand, et al., “Rationale and Efficacy of Interleukin-1 Targeting in Erdheim-Chester Disease,” Blood, Vol. 116, No. 20, 2012, pp. 4070-4076. doi:10.1182/blood-2010-04-279240 [3] W. Chester, “über Lipoidgranulomatose,” Virchows Archive, Vol. 279, No. 2, 1930, pp. 561-602. doi:10.1007/BF01942684 [4] J. Haroche, P. Cluzel, D. Toledano, G. Montalescot, D. Touitou, et al., “Cardiac Involvement in Erdheim-Chester Disease: Magnetic Resonance and Computed Tomographic Scan Imaging in a Monocentric Series of 37 Patients,” Circulation, Vol. 119, No. 25, 2009, pp. e597-e598. doi:10.1161/CIRCULATIONAHA.108.825075 [5] E. C. Derrett-Smith and B. Dasgupta, “Erdheim-Chester Disease: Yet another Mimic of Polymyalgia Rheumatica and Giant Cell Arteritis?” Rheumatology, Vol. 44, No. 3, 2005, pp. iii14-iii15.